Related Experiment Video

Updated: Jul 19, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Complete nucleotide sequence of genotype 4 hepatitis C viruses isolated from patients co-infected with human

Sandra Franco1, Cristina Tural, Bonaventura Clotet

  • 1Fundació irsiCaixa, Universitat Autònoma de Barcelona, Spain.

Virus Research
|October 7, 2006
PubMed

Insights

Hepatitis C virus (HCV) genotype 4, often found in co-infected patients with human immunodeficiency virus type 1 (HIV-1), shows poor response to interferon therapy. This study sequenced two HCV genotype 4 variants, revealing new subtypes and insights into viral evolution and treatment response.

Area of Science:

  • Virology
  • Genetics
  • Immunology

Background:

  • Hepatitis C virus (HCV) genotype 4 is prevalent in Southern European intravenous drug users, frequently co-infected with HIV-1.
  • Treatment response to interferon-based therapies is poor for HCV genotype 4 in HIV-1 positive patients, similar to genotype 1 and worse than genotypes 2 and 3.

Purpose of the Study:

  • To sequence and analyze the complete genomes of two HCV genotype 4 variants from HIV-1 co-infected patients.
  • To investigate the evolutionary relationships of these variants with other HCV genotypes and subtypes.
  • To explore potential reasons for poor treatment response in genotype 4 infections.

Main Methods:

  • Complete genome sequencing of two HCV genotype 4 variants from HIV-1 co-infected patients.
  • Phylogenetic analysis using genomic regions 5'NC, core-E1, and NS5B.
  • Subtyping using INNO-LIPA II HCV assay.
  • Analysis of sequence length differences in interferon sensitivity determining regions.
  • Determination of NS3/4 protease catalytic efficiency.

Main Results:

  • The sequenced variants were identified as subtypes 4d and 4a, with one variant representing a new subtype within genotype 4.
  • Sequence analysis revealed differences in the interferon sensitivity determining region compared to other genotypes.
  • The catalytic efficiency of NS3/4 proteases from the studied variants was significantly lower than that of genotype 1 proteases.
  • Phylogenetic analysis indicated that genotype 4 sequences are more closely related to genotype 1 sequences.

Conclusions:

  • The characterization of new HCV genotype 4 variants provides valuable data for understanding HCV evolution and subtype diversity.
  • Observed genetic differences may contribute to the poor response to interferon therapy in patients with HCV genotype 4 and HIV-1 co-infection.
  • Further research into HCV genotypes and their biological mechanisms is crucial for improving treatment strategies and patient outcomes.

More Related Videos

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...